Ampio Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ampio Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2023.
  • Ampio Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$2.05M, a 7.48% increase year-over-year.
  • Ampio Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$8.63M, a 47.2% increase year-over-year.
  • Ampio Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.63M, a 47.2% increase from 2022.
  • Ampio Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$16.3M, a 4.32% increase from 2021.
  • Ampio Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.1M, a 7.43% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$8.63M -$2.05M +$166K +7.48% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$8.8M -$1.23M +$5.18M +80.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$14M -$1.37M +$699K +33.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-14
Q1 2023 -$14.7M -$3.98M +$1.66M +29.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-14
Q4 2022 -$16.3M -$2.22M +$4M +64.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$20.3M -$6.41M -$2.78M -76.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$17.6M -$2.07M +$1.49M +41.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$19M -$5.64M -$1.97M -53.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$17.1M -$6.22M -$1.61M -34.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$15.5M -$3.63M -$260K -7.72% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$15.2M -$3.56M -$825K -30.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$14.4M -$3.67M +$1.51M +29.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$15.9M -$4.62M -$3.6M -353% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$12.3M -$3.37M +$3.85M +53.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$16.1M -$2.73M -$3.15M -749% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$13M -$5.18M +$633K +10.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$13.6M -$1.02M -$2.55M -167% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$11.1M -$7.22M -$13M -224% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $1.94M $421K -$4.2M -90.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $6.13M -$5.81M -$27.9M -126% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $34M $1.53M +$44.7M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 -$10.7M $5.8M +$10.1M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$20.7M $4.62M +$7.23M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$27.9M $22M +$23.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$51.9M -$43.1M -$39.8M -1186% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$12.1M -$4.25M -$261K -6.53% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$11.9M -$2.61M +$2.44M +48.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$14.3M -$1.9M +$4.86M +71.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$19.2M -$3.35M +$6.65M +66.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$25.8M -$3.99M +$3.16M +44.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$29M -$5.05M +$2.3M +31.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$31.3M -$6.76M +$519K +7.12% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$31.8M -$10M -$94K -0.95% Oct 1, 2015 Dec 31, 2015 10-K 2016-02-26
Q3 2015 -$31.7M -$7.16M +$2.12M +22.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$33.8M -$7.36M +$1.34M +15.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$35.2M -$7.28M +$2.96M +28.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$38.1M -$9.91M -$2.57M -35% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 -$35.6M -$9.28M -$3.21M -52.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$32.3M -$8.69M -$2.27M -35.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 -$30.1M -$10.2M -$6.06M -145% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 -$24M -$7.34M -$3.66M -99.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 -$20.3M -$6.07M -$3.49M -135% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 -$16.9M -$6.42M -$3.92M -157% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 -$12.9M -$4.18M -$1.34M -47.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 -$11.6M -$3.68M +$509K +12.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-14
Q3 2012 -$12.1M -$2.58M -$8.34K -0.32% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-14
Q2 2012 -$12.1M -$2.5M +$322K +11.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-14
Q1 2012 -$12.4M -$2.84M +$5.94M +67.7% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-14
Q4 2011 -$18.4M -$4.19M Oct 1, 2011 Dec 31, 2011 10-Q 2014-05-07
Q3 2011 -$2.58M -$132K -5.41% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$2.82M -$1.67M -146% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$8.78M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$2.44M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 -$1.15M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.